Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial

2014724 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 385, Issue 9965, pp. 341-350

Field-Weighted Citation Impact: 90.63